Farnaz Nowroozi, Ph.D. - Publications

2009 Bioengineering University of California, Berkeley, Berkeley, CA 
Metabolic engineering of microorganisms

6 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Nowroozi FF, Baidoo EE, Ermakov S, Redding-Johanson AM, Batth TS, Petzold CJ, Keasling JD. Metabolic pathway optimization using ribosome binding site variants and combinatorial gene assembly. Applied Microbiology and Biotechnology. 98: 1567-81. PMID 24257840 DOI: 10.1007/S00253-013-5361-4  0.48
2010 Kirby J, Nishimoto M, Park JG, Withers ST, Nowroozi F, Behrendt D, Rutledge EJ, Fortman JL, Johnson HE, Anderson JV, Keasling JD. Cloning of casbene and neocembrene synthases from Euphorbiaceae plants and expression in Saccharomyces cerevisiae. Phytochemistry. 71: 1466-73. PMID 20594566 DOI: 10.1016/J.Phytochem.2010.06.001  0.48
2009 Anthony JR, Anthony LC, Nowroozi F, Kwon G, Newman JD, Keasling JD. Optimization of the mevalonate-based isoprenoid biosynthetic pathway in Escherichia coli for production of the anti-malarial drug precursor amorpha-4,11-diene. Metabolic Engineering. 11: 13-9. PMID 18775787 DOI: 10.1016/J.Ymben.2008.07.007  0.48
2008 Yoshikuni Y, Dietrich JA, Nowroozi FF, Babbitt PC, Keasling JD. Redesigning enzymes based on adaptive evolution for optimal function in synthetic metabolic pathways. Chemistry & Biology. 15: 607-18. PMID 18559271 DOI: 10.1016/J.Chembiol.2008.05.006  0.48
2007 Suthers PF, Burgard AP, Dasika MS, Nowroozi F, Van Dien S, Keasling JD, Maranas CD. Metabolic flux elucidation for large-scale models using 13C labeled isotopes. Metabolic Engineering. 9: 387-405. PMID 17632026 DOI: 10.1016/J.Ymben.2007.05.005  0.48
2006 Newman JD, Marshall J, Chang M, Nowroozi F, Paradise E, Pitera D, Newman KL, Keasling JD. High-level production of amorpha-4,11-diene in a two-phase partitioning bioreactor of metabolically engineered Escherichia coli. Biotechnology and Bioengineering. 95: 684-91. PMID 16878333 DOI: 10.1002/Bit.21017  0.48
Show low-probability matches.